상세정보
Export to Refworks부가기능
Vasoactive Intestinal Peptide Nanomedicine for the Treatment of Inflammatory Bowel Disease
상세 프로파일
| 자료유형 | 학위논문 |
|---|---|
| 서명/저자사항 | Vasoactive Intestinal Peptide Nanomedicine for the Treatment of Inflammatory Bowel Disease. |
| 개인저자 | Jayawardena, Dulari. |
| 단체저자명 | University of Illinois at Chicago. Biopharmaceutical Sciences. |
| 발행사항 | [S.l.]: University of Illinois at Chicago., 2018. |
| 발행사항 | Ann Arbor: ProQuest Dissertations & Theses, 2018. |
| 형태사항 | 231 p. |
| 기본자료 저록 | Dissertation Abstracts International 79-12B(E). Dissertation Abstract International |
| ISBN | 9780438265035 |
| 학위논문주기 | Thesis (Ph.D.)--University of Illinois at Chicago, 2018. |
| 일반주기 |
Source: Dissertation Abstracts International, Volume: 79-12(E), Section: B.
Advisers: Hayat Onyuksel |
| 요약 | Vasoactive intestinal peptide (VIP) is an endogenous neuropeptide with a wide array of immunomodulatory properties. VIP has shown beneficial effects in managing multiple inflammatory disorders, including inflammatory bowel disease (IBD). IBD inc |
| 일반주제명 | Pharmacology. Molecular biology. Pharmaceutical sciences. |
| 언어 | 영어 |
| 바로가기 | 
: 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |
